Pancreatitis, very early compared with normal start of enteral feeding (PYTHON trial): design and rationale of a randomised controlled multicenter trial

<p>Abstract</p> <p>Background</p> <p>In predicted severe acute pancreatitis, infections have a negative effect on clinical outcome. A start of enteral nutrition (EN) within 24 hours of onset may reduce the number of infections as compared to the current practice of star...

Full description

Bibliographic Details
Main Authors: Schaapherder Alexander F, van Ramshorst Bert, Nieuwenhuijs Vincent B, Manusama Eric R, Karsten Thom M, Jansen Jeroen M, Houdijk Alexander P, Heisterkamp Joos, van Goor Harry, van Geenen Erwin J, Dejong Cornelis H, Brink Menno A, Bosscha Koop, Bollen Thomas L, Boermeester Marja A, Besselink Marc G, Ali Usama, van Brunschot Sandra, van Santvoort Hjalmar C, Bakker Olaf J, van der Schelling George P, Spanier Marcel BM, Tan Adriaan, Vecht Juda, Weusten Bas L, Witteman Ben J, Akkermans Louis M, Gooszen Hein G
Format: Article
Language:English
Published: BMC 2011-03-01
Series:Trials
Online Access:http://www.trialsjournal.com/content/12/1/73
_version_ 1811246109810491392
author Schaapherder Alexander F
van Ramshorst Bert
Nieuwenhuijs Vincent B
Manusama Eric R
Karsten Thom M
Jansen Jeroen M
Houdijk Alexander P
Heisterkamp Joos
van Goor Harry
van Geenen Erwin J
Dejong Cornelis H
Brink Menno A
Bosscha Koop
Bollen Thomas L
Boermeester Marja A
Besselink Marc G
Ali Usama
van Brunschot Sandra
van Santvoort Hjalmar C
Bakker Olaf J
van der Schelling George P
Spanier Marcel BM
Tan Adriaan
Vecht Juda
Weusten Bas L
Witteman Ben J
Akkermans Louis M
Gooszen Hein G
author_facet Schaapherder Alexander F
van Ramshorst Bert
Nieuwenhuijs Vincent B
Manusama Eric R
Karsten Thom M
Jansen Jeroen M
Houdijk Alexander P
Heisterkamp Joos
van Goor Harry
van Geenen Erwin J
Dejong Cornelis H
Brink Menno A
Bosscha Koop
Bollen Thomas L
Boermeester Marja A
Besselink Marc G
Ali Usama
van Brunschot Sandra
van Santvoort Hjalmar C
Bakker Olaf J
van der Schelling George P
Spanier Marcel BM
Tan Adriaan
Vecht Juda
Weusten Bas L
Witteman Ben J
Akkermans Louis M
Gooszen Hein G
author_sort Schaapherder Alexander F
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>In predicted severe acute pancreatitis, infections have a negative effect on clinical outcome. A start of enteral nutrition (EN) within 24 hours of onset may reduce the number of infections as compared to the current practice of starting an oral diet and EN if necessary at 3-4 days after admission.</p> <p>Methods/Design</p> <p>The PYTHON trial is a randomised controlled, parallel-group, superiority multicenter trial. Patients with predicted severe acute pancreatitis (Imrie-score ≥ 3 or APACHE-II score ≥ 8 or CRP > 150 mg/L) will be randomised to EN within 24 hours or an oral diet and EN if necessary, after 72 hours after hospital admission.</p> <p>During a 3-year period, 208 patients will be enrolled from 20 hospitals of the Dutch Pancreatitis Study Group. The primary endpoint is a composite of mortality or infections (bacteraemia, infected pancreatic or peripancreatic necrosis, pneumonia) during hospital stay or within 6 months following randomisation. Secondary endpoints include other major morbidity (e.g. new onset organ failure, need for intervention), intolerance of enteral feeding and total costs from a societal perspective.</p> <p>Discussion</p> <p>The PYTHON trial is designed to show that a very early (< 24 h) start of EN reduces the combined endpoint of mortality or infections as compared to the current practice of an oral diet and EN if necessary at around 72 hours after admission for predicted severe acute pancreatitis.</p> <p>Trial Registration</p> <p>ISRCTN: <a href="http://www.controlled-trials.com/ISRCTN18170985">ISRCTN18170985</a></p>
first_indexed 2024-04-12T14:48:54Z
format Article
id doaj.art-4f69ecc3f4df436eaed420dc14b16e06
institution Directory Open Access Journal
issn 1745-6215
language English
last_indexed 2024-04-12T14:48:54Z
publishDate 2011-03-01
publisher BMC
record_format Article
series Trials
spelling doaj.art-4f69ecc3f4df436eaed420dc14b16e062022-12-22T03:28:32ZengBMCTrials1745-62152011-03-011217310.1186/1745-6215-12-73Pancreatitis, very early compared with normal start of enteral feeding (PYTHON trial): design and rationale of a randomised controlled multicenter trialSchaapherder Alexander Fvan Ramshorst BertNieuwenhuijs Vincent BManusama Eric RKarsten Thom MJansen Jeroen MHoudijk Alexander PHeisterkamp Joosvan Goor Harryvan Geenen Erwin JDejong Cornelis HBrink Menno ABosscha KoopBollen Thomas LBoermeester Marja ABesselink Marc GAli Usamavan Brunschot Sandravan Santvoort Hjalmar CBakker Olaf Jvan der Schelling George PSpanier Marcel BMTan AdriaanVecht JudaWeusten Bas LWitteman Ben JAkkermans Louis MGooszen Hein G<p>Abstract</p> <p>Background</p> <p>In predicted severe acute pancreatitis, infections have a negative effect on clinical outcome. A start of enteral nutrition (EN) within 24 hours of onset may reduce the number of infections as compared to the current practice of starting an oral diet and EN if necessary at 3-4 days after admission.</p> <p>Methods/Design</p> <p>The PYTHON trial is a randomised controlled, parallel-group, superiority multicenter trial. Patients with predicted severe acute pancreatitis (Imrie-score ≥ 3 or APACHE-II score ≥ 8 or CRP > 150 mg/L) will be randomised to EN within 24 hours or an oral diet and EN if necessary, after 72 hours after hospital admission.</p> <p>During a 3-year period, 208 patients will be enrolled from 20 hospitals of the Dutch Pancreatitis Study Group. The primary endpoint is a composite of mortality or infections (bacteraemia, infected pancreatic or peripancreatic necrosis, pneumonia) during hospital stay or within 6 months following randomisation. Secondary endpoints include other major morbidity (e.g. new onset organ failure, need for intervention), intolerance of enteral feeding and total costs from a societal perspective.</p> <p>Discussion</p> <p>The PYTHON trial is designed to show that a very early (< 24 h) start of EN reduces the combined endpoint of mortality or infections as compared to the current practice of an oral diet and EN if necessary at around 72 hours after admission for predicted severe acute pancreatitis.</p> <p>Trial Registration</p> <p>ISRCTN: <a href="http://www.controlled-trials.com/ISRCTN18170985">ISRCTN18170985</a></p>http://www.trialsjournal.com/content/12/1/73
spellingShingle Schaapherder Alexander F
van Ramshorst Bert
Nieuwenhuijs Vincent B
Manusama Eric R
Karsten Thom M
Jansen Jeroen M
Houdijk Alexander P
Heisterkamp Joos
van Goor Harry
van Geenen Erwin J
Dejong Cornelis H
Brink Menno A
Bosscha Koop
Bollen Thomas L
Boermeester Marja A
Besselink Marc G
Ali Usama
van Brunschot Sandra
van Santvoort Hjalmar C
Bakker Olaf J
van der Schelling George P
Spanier Marcel BM
Tan Adriaan
Vecht Juda
Weusten Bas L
Witteman Ben J
Akkermans Louis M
Gooszen Hein G
Pancreatitis, very early compared with normal start of enteral feeding (PYTHON trial): design and rationale of a randomised controlled multicenter trial
Trials
title Pancreatitis, very early compared with normal start of enteral feeding (PYTHON trial): design and rationale of a randomised controlled multicenter trial
title_full Pancreatitis, very early compared with normal start of enteral feeding (PYTHON trial): design and rationale of a randomised controlled multicenter trial
title_fullStr Pancreatitis, very early compared with normal start of enteral feeding (PYTHON trial): design and rationale of a randomised controlled multicenter trial
title_full_unstemmed Pancreatitis, very early compared with normal start of enteral feeding (PYTHON trial): design and rationale of a randomised controlled multicenter trial
title_short Pancreatitis, very early compared with normal start of enteral feeding (PYTHON trial): design and rationale of a randomised controlled multicenter trial
title_sort pancreatitis very early compared with normal start of enteral feeding python trial design and rationale of a randomised controlled multicenter trial
url http://www.trialsjournal.com/content/12/1/73
work_keys_str_mv AT schaapherderalexanderf pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT vanramshorstbert pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT nieuwenhuijsvincentb pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT manusamaericr pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT karstenthomm pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT jansenjeroenm pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT houdijkalexanderp pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT heisterkampjoos pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT vangoorharry pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT vangeenenerwinj pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT dejongcornelish pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT brinkmennoa pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT bosschakoop pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT bollenthomasl pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT boermeestermarjaa pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT besselinkmarcg pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT aliusama pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT vanbrunschotsandra pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT vansantvoorthjalmarc pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT bakkerolafj pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT vanderschellinggeorgep pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT spaniermarcelbm pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT tanadriaan pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT vechtjuda pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT weustenbasl pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT wittemanbenj pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT akkermanslouism pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial
AT gooszenheing pancreatitisveryearlycomparedwithnormalstartofenteralfeedingpythontrialdesignandrationaleofarandomisedcontrolledmulticentertrial